Clinical Trial Update: Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis

View source ↗

Summary

A completed Osaka City University clinical trial explored whether hepatic CYP3A activity influences susceptibility to avascular necrosis of the femoral head.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head

Snippet

Sponsor: Osaka City University | Conditions: Femur Head Necrosis | Status: COMPLETED